Skip to content
Home/Companies/MedTech/BioVendor Group

BioVendor Group

MedTech·Czech Republic·Active·1yr hold
Entry
2025
Hold
1yr
Status
Active

Who owns BioVendor Group?

BioVendor Group is a Czech MedTech company, currently owned by ARCHIMED since 2025.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
ARCHIMED
Investor
ARCHIMED
MED III · 2021 · Buyout

Key facts

HQCzech Republic
SectorMedTech

More from MED III

Other portfolio companies in the same fund.

DermaPharm
DermaPharm
Active
HealthTechDenmark· 2025
Natus Sensory
Natus Sensory
Active
MedTechUS· 2022
PlasmidFactory
PlasmidFactory
Active
BiotechGermany· 2022
Title21 Health Solutions
Title21 Health Solutions
Active
HealthTechUS· 2022
Aliri
Aliri
Active
PharmaUS· 2021
Cardioline
Cardioline
Active
MedTechItaly· 2021

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany

Questions

Who owns BioVendor Group?

BioVendor Group is currently owned by ARCHIMED, through MED III, since 2025.

When did ARCHIMED acquire BioVendor Group?

ARCHIMED acquired BioVendor Group in 2025.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue